XML 49 R38.htm IDEA: XBRL DOCUMENT v3.21.2
Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details) - USD ($)
$ in Millions
3 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Restructuring Reserve [Roll Forward]    
Beginning balance $ 151  
Restructuring, impairment, and related charges 158 $ 56
Non-cash charges (104)  
Cash payments (21)  
Other (7)  
Ending balance 177  
International    
Restructuring Reserve [Roll Forward]    
Restructuring, impairment, and related charges 6 14
Operating Segments | U.S. Pharmaceutical    
Restructuring Reserve [Roll Forward]    
Beginning balance 19  
Restructuring, impairment, and related charges 12 2
Non-cash charges (8)  
Cash payments (5)  
Other 0  
Ending balance 18  
Operating Segments | Prescription Technology Solutions    
Restructuring Reserve [Roll Forward]    
Beginning balance 4  
Restructuring, impairment, and related charges 18 0
Non-cash charges (17)  
Cash payments (1)  
Other 0  
Ending balance 4  
Operating Segments | Medical-Surgical Solutions    
Restructuring Reserve [Roll Forward]    
Beginning balance 3  
Restructuring, impairment, and related charges 6 3
Non-cash charges (4)  
Cash payments (2)  
Other (1)  
Ending balance 2  
Operating Segments | International    
Restructuring Reserve [Roll Forward]    
Beginning balance 66  
Restructuring, impairment, and related charges 60 23
Non-cash charges (34)  
Cash payments (5)  
Other (3)  
Ending balance 84  
Corporate    
Restructuring Reserve [Roll Forward]    
Beginning balance 59  
Restructuring, impairment, and related charges 62 $ 28
Non-cash charges (41)  
Cash payments (8)  
Other (3)  
Ending balance 69  
Other accrued liabilities    
Restructuring Reserve [Roll Forward]    
Beginning balance 99  
Ending balance 127  
Other noncurrent liabilities    
Restructuring Reserve [Roll Forward]    
Beginning balance 52  
Ending balance $ 50